These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24960280)

  • 1. Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses.
    Rotroff DM; Martin MT; Dix DJ; Filer DL; Houck KA; Knudsen TB; Sipes NS; Reif DM; Xia M; Huang R; Judson RS
    Environ Sci Technol; 2014; 48(15):8706-16. PubMed ID: 24960280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
    Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.
    Judson RS; Magpantay FM; Chickarmane V; Haskell C; Tania N; Taylor J; Xia M; Huang R; Rotroff DM; Filer DL; Houck KA; Martin MT; Sipes N; Richard AM; Mansouri K; Setzer RW; Knudsen TB; Crofton KM; Thomas RS
    Toxicol Sci; 2015 Nov; 148(1):137-54. PubMed ID: 26272952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.
    Brennan JC; Bassal A; He G; Denison MS
    Environ Toxicol Chem; 2016 Jan; 35(1):91-100. PubMed ID: 26139245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
    Witters H; Freyberger A; Smits K; Vangenechten C; Lofink W; Weimer M; Bremer S; Ahr PH; Berckmans P
    Reprod Toxicol; 2010 Aug; 30(1):60-72. PubMed ID: 20362049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
    Zang Q; Rotroff DM; Judson RS
    J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust array-based coregulator binding assay predicting ERα-agonist potency and generating binding profiles reflecting ligand structure.
    Aarts JM; Wang S; Houtman R; van Beuningen RM; Westerink WM; Van De Waart BJ; Rietjens IM; Bovee TF
    Chem Res Toxicol; 2013 Mar; 26(3):336-46. PubMed ID: 23383871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.
    Judson RS; Houck KA; Watt ED; Thomas RS
    Regul Toxicol Pharmacol; 2017 Dec; 91():39-49. PubMed ID: 28993267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 155-plex high-throughput in vitro coregulator binding assay for (anti-)estrogenicity testing evaluated with 23 reference compounds.
    Wang S; Houtman R; Melchers D; Aarts J; Peijnenburg A; van Beuningen R; Rietjens I; Bovee TF
    ALTEX; 2013; 30(2):145-57. PubMed ID: 23665804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
    Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
    Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.
    Ankley GT; LaLone CA; Gray LE; Villeneuve DL; Hornung MW
    Environ Toxicol Chem; 2016 Nov; 35(11):2806-2816. PubMed ID: 27074246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.
    Ryan N; Chorley B; Tice RR; Judson R; Corton JC
    Toxicol Sci; 2016 May; 151(1):88-103. PubMed ID: 26865669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.
    Wang S; Rijk JC; Besselink HT; Houtman R; Peijnenburg AA; Brouwer A; Rietjens IM; Bovee TF
    Toxicol Sci; 2014 Sep; 141(1):78-89. PubMed ID: 24928889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
    Cosnefroy A; Brion F; Maillot-Maréchal E; Porcher JM; Pakdel F; Balaguer P; Aït-Aïssa S
    Toxicol Sci; 2012 Feb; 125(2):439-49. PubMed ID: 22045033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of human estrogen receptor agonistic/antagonistic effects of veterinary drugs used for livestock and farmed fish by OECD in vitro stably transfected transcriptional activation assays.
    Lee HS; Kim NY; Song Y; Oh GY; Jung DW; Jeong DH; Kang HS; Oh HS; Park Y; Hong JS; Koo YE
    Toxicol In Vitro; 2019 Aug; 58():256-263. PubMed ID: 30742918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
    Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
    Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nonmonotonic concentration-responses in Tox21 high-throughput screening estrogen receptor assays.
    Shi Z; Xia M; Xiao S; Zhang Q
    Toxicol Appl Pharmacol; 2022 Oct; 452():116206. PubMed ID: 35988584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of cellular estrogen signaling in representative estrogen receptor ligands.
    Seo H; Seo H; Lee HY; Lee SH; Park Y
    Chem Biol Interact; 2023 Jan; 369():110303. PubMed ID: 36513145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells.
    Rotroff DM; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Reif DM; Richard AM; Sipes NS; Abassi YA; Jin C; Stampfl M; Judson RS
    Chem Res Toxicol; 2013 Jul; 26(7):1097-107. PubMed ID: 23682706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.